Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1630-1636

  Kube, D ^a,b,g   Vockerodt, M ^a,b   Weber, O ^e   Hell, K ^c   Wolf, J ^a   Haier, B ^a   Grasser F A ^d   Muller Lantzsch N ^d   Kieff, E ^f   Diehl, V ^a   Tesch, H ^a  

^a Klin III F Inn Medizin Kardiologie Angiologie Pneumologie und Internistische Intensivmedizin   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e BAYER AG   (Germany)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; CD71 ANTIGEN; CELL NUCLEUS ANTIGEN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LYMPHOTOXIN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REED STERNBERG CELL; SCID MOUSE;

EID: 0032926452     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1630-1636.1999     Document Type: Article

References (39)

1. Anagnostopoulos, I., H. Herbst, G. Niedobitek, and H. Stein. 1989 Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-I-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 74:810-816.
2. Anagnostopoulos, I., M. Hummel, and H. Stein. 1996. Epstein-Barr virus and Hodgkin's disease. Forum. Trends Exp. Clin. Med. 6:36-50.
3. Armstrong, A. A., L. M. Weiss, A. Gallagher, D. B. Jones, A. S. Krajewski, B. Angus, G. Brown, A. S. Jack, B. S. Wilkins, D. E. Onions, et al. 1992. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia 6:869-874.
4. Burton, J., and N. E. Kay. 1994. Does IL-2 receptor expression and secretion in chronic B-cell leukemia have a role in down-regulation of the immune system? Leukemia 8:92-96.
5. Chen, F., J. Z. Zou, L. di Renzo, G. Winberg, L. F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1, J. Virol. 69:3752-3758.
6. Cruchley, A. T., D. M. Williams, G. Niedobitek, and L. S. Young. 1997. Epstein-Barr virus: biology and disease. Oral Dis. 3(Suppl. 1):156-163.
7. Deacon, E. M, G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks, A. B. Rickinson, and L. S. Young. 1993. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177:339-349.
8. deTotero, D., C. P. di Francia, A. Cignetti, and R. Foa. 1995. The IL-2 receptor complex: expression and function on normal and leukemic B cells. Leukemia 9:1425-1431.
9. Diehl, V., H. H. Kirchner, M. Schaadt, C. Fonatsch, H. Stein, J. Gerdes, and C. Boie. 1981. Hodgkin's disease: establishment and characterization of four in vitro cell lines. J. Cancer Res. Clin. Oncol. 101:111-124.
10. Gorschluter, M., H. Bohlen, D. Hasenclever, V. Diehl, and H. Tesch. 1995. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Ann. Oncol. 6:477-482.
11. Grasser, F., P. G. Murray, E. Kremmer, K. Klein, K. Remberger, W. Feiden, G. Reynolds, G. Niedobitek, L. S. Young, and L. N. Mueller. 1994. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA-1): immunohistologic detection of EBNA-1 in the malignant cells of Hodgkin's disease. Blood 84:3792-3978.
12. Herbst, H., F. Dallenbach, M. Hummel, G. Niedobitek, S. Pileri, L. N. Muller, and H. Stein. 1991. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 88:4766-4770.
13. Herbst, H., T. Raff, and H. Stein, 1996. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J. Pathol. 179:54-59.
14. Herbst, H., H. D. Foss, J. Samol, I. Araujo, H. Klotzbach, H. Krause, A. Agathanggelou, G. Niedobitek, and H. Stein, 1996. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 87:2918-2929.
15. Hsu, M. M., Y. J. Chen, Y. L. Chang, J. Y. Ko, and T. S. Sheen. 1995. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma. Asian Pac. J. Allergy Immunol. 13:1-4.
16. Kanzler, H., R-Kuppers, M. L. Hansmann, and K. Rajewsky. 1996. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1495-1505.
17. Karnitz, L. M., and R. T. Abraham. 1996. Interleukin-2 receptor signaling mechanisms. Adv. Immunol. 61:147-199.
18. Khan, G., and M. A. Naase. 1995. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease. J. Clin. Pathol. 48:845-848.
19. Klein, S., M. Jucker, V. Diehl, and H. Tesch. 1992. Production of multiple cytokines by Hodgkin's disease derived cell lines. Hematol. Oncol. 10:319-329.
20. Klein, S. C., D. Kube, H. Abts, V. Diehl, and H. Tesch, 1996. Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection. Leuk. Res. 20:633-636.
21. Kuhn, H. I., D. R. Sage, L. Stein, H. Groelle, and J. D. Fingeroth. 1995. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood 85:1289-1299.
22. McKay, C. E., and W. Cushley. 1996. Induction of CD25 expression in human B lymphocytes by pharmacological activators of cellular signalling pathways. Cytokine 8:305-312.
23. Mueller, N. 1987. Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease. Yale J. Biol. Med. 60:321-332.
24. Niedobitek, G., E. Kremmer, H. Herbst, L. Whitehead, C. W. Dawson, E. Niedobitek, C. von Ostau, N. Rooney, F. A. Grasser, and L. S. Young. 1997. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 90:1664-1672.
25. Oudejans, J. J., D. F. Dukers, N. M. Jiwa, A. J. van den Brule, F. A. Grasser, P. C. de Bruin, A. Horstman, W. Vos, J. van Gorp, J. M. Middeldorp, and C. J. Meijer. 1996. Expression of Epstein-Barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV. J. Clin. Pathol. 49:897-902.
26. Rickinson, A, and E. Kieff. 1996. Biology of EBV, p. 2397-2446. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.). Fields virology. Lippincott-Raven, New York, N.Y.
27. Snudden, D. K., J. Hearing, P. R. Smith, F. A. Grasser, and B. E. Grifin. 1994. EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J. 13:4840-4847.
28. Srinivas, S. K., and J. W. Sixbey. 1995. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J. Virol. 69:8155-8158.
29. Tesch. H., M. Jucker, S. Klein, H. Abts, A. Gunther, G. R. Krueger, and V. Diehl. 1992. Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors. Leuk. Lymphoma 7:297-303.
30. Tesch, H., A. C. Feller, M. Jucker, S. Klein, H. Merz, and V. Diehl. 1992. Activation of cytokines in Hodgkin's disease. Ann. Oncol. 4:13-16.
31. Tesch, H., A. Gunther, H. Abts, M. Jucker, S. Klein, G. R. Krueger, and V. Diehl. 1993. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. Am. J. Pathol. 142:1714-1720.
32. Tsilivakos, V, A. Tsapis, S. Kakolyris, P. Iliakis, M. Perraki, and V. Georgoulias. 1994. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells. Leukemia 8:1571-1578.
33. Vasef, M. A., O. W. Kamel, Y. Y. Chen, L. J. Medeiros, and L. M. Weiss. 1995. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am. J. Pathol. 147:1408-1415.
34. van Kalle, C., J. Wolf, A. Becker, A. Scaer, M. Munck, A. Engert, U. Kapp, C. Fonatsch, D. Komitowski, W. Fe'aux Delacroix, and V. Diehl. 1992. Growth of Hodgkin's cell lines in severly combined immunodeflcient mice. Int. J. Cancer 52:887-891.
35. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
36. Weiss, L. M., and K. L. Chang. 1992. Molecular biologic studies of Hodgkin's disease. Semin. Diagn. Pathol. 9:272-278.
37. Westermann, F., D. Kube, B. Haier, H. Bohlen, A. Engert, M. Zuehlsdorf, V. Diehl, and H. Tesch. 1996. Interleukin 10 inhibits cytokine production of human AML cells. Ann. Oncol. 7:397-404.
38. Willerford, D. M., J. Chen, J. A. Ferry, L Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530.
39. Wilson, J. B., J. L. Bell, and A. J. Levine. 1996. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15:3117-3126.